Turkey Offlabel indicationINVESTIGATIONAL USE For adjunctive use in the treatment of severe acute respiratorysyndrome coronavirus 2 SARSCoV2 infection the virus that causes coronavirus d ID: 831346
Download Pdf The PPT/PDF document "expand all" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Turkeyexpand allâ
Turkeyexpand allâ
Off-label indica
Off-label indica
tionINVESTIGATIONAL
tionINVESTIGATIONAL
USE: For adjunctiv
USE: For adjunctiv
e use in the treatm
e use in the treatm
ent of severe acute
ent of severe acute
respiratorysyndrom
respiratorysyndrom
e coronavirus 2 (SA
e coronavirus 2 (SA
RS-CoV-2) infection
RS-CoV-2) infection
â , the virus that
â , the virus that
causes coronavirus
causes coronavirus
disease 2019Effic
disease 2019Effic
acy has not been es
acy has not been es
tablished. Due to b
tablished. Due to b
road immunosuppress
road immunosuppress
ive effects, the Na
ive effects, the Na
tional Institutes o
tional Institutes o
f Health (NIH) COVI
f Health (NIH) COVI
D-Efficacy has not
D-Efficacy has not
been established.
been established.
Due to broad immuno
Due to broad immuno
suppressive effects
suppressive effects
, the National Inst
, the National Inst
itutes of Health (N
itutes of Health (N
IH) COVID-PO twice
IH) COVID-PO twice
daily for 2 days, t
daily for 2 days, t
hen 5 mg PO once da
hen 5 mg PO once da
ily for 1 day.For t
ily for 1 day.For t
he treatment of pol
he treatment of pol
ycythemia verafor t
ycythemia verafor t
he treatment of pol
he treatment of pol
ycythemia vera in p
ycythemia vera in p
atients who have ha
atients who have ha
d an inadequate res
d an inadequate res
ponse to or are int
ponse to or are int
olerantof hydroxyur
olerantof hydroxyur
ea(SARS-CoV-2) inf
ea(SARS-CoV-2) inf